Health Discovery (HDC) signed a nonexclusive worldwide agreement with Bruker Daltonics covering Bruker’s use of HDC’s Support Vector Machine (SVM) technology in the ClinProTools™ clinical proteomics product line.

ClinProTools is Bruker Daltonics’ bioinformatics solution for biomarker panel analysis, biofluid profiling, multivariate data analysis of large sample sets, classical statistics, and sample classification.

“SVMs are high-performance supervised classification algorithms that can analyze high-dimensional mass spectrometric data from many sample sets and they complement the use of other classification algorithms such as Bruker’s Supervised Neural Network™ and QuickClassifier™,” explains Michael Shubert, executive vp, Bruker Daltonics.

Previous articleEnzon and Santaris to Collaborate on Novel Cancer Drugs
Next articleGenomic Code for the Packaging of DNA within Nucleosomes Discovered